Deutsch English Français

Contact

EP0050129

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP0050129

EP0050129 - MONOCLONAL ANTIBODY [Right-click to bookmark this link]
Status	Opposition procedure closed Status updated on 03.08.1995 Database last updated on 29.03.2025
Most recent event Tooltip	05.10.2005	Change: Appeal number
Applicant(s)	For all designated states CELLTECH LIMITED 216 Bath Road Slough Berkshire SL1 4EN / GB
	For all designated states BURKE, Derek C. 41 Portland Street Leamington Spa Warwicks CV32 5EY / GB
	[N/P]
Former [1992/01]	For all designated states CELLTECH LIMITED 216 Bath Road Slough Berkshire SL1 4EN / GB
	For all designated states BURKE, Derek C. 41 Portland Street Leamington Spa Warwicks CV32 5EY / GB
Former [1982/17]	For all designated states SECHER, David Stanley 2 Nightingale Avenue Cambridge CB1 4SQ / GB
	For all designated states BURKE, Derek C. 41 Portland Street Leamington Spa Warwicks CV32 5EY / GB
Inventor(s)	01 / Secher, David Stanley 2 Nightingale Avenue Cambridge CB1 4SQ / GB
	02 / Burke, Derek C. 7 Highgate Road Toronto, Canada M8X 2B1 / CA
	[1992/12]
Former [1982/17]	01 / see applicant ...
Representative(s)	Votier, Sidney David, et al CARPMAELS & RANSFORD 43, Bloomsbury Square London WC1A 2RA / GB
	[1982/17]
Application number, filing date	81900967.1	13.04.1981
	[1982/17]
	WO1981GB00067
Priority number, date	GB19800012096	11.04.1980 Original published format: GB 8012096
	GB19800035884	07.11.1980 Original published format: GB 8035884
	[1982/17]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO8102899
	Date:	15.10.1981
	[1981/24]
	Type:	A1 Application with search report
	No.:	EP0050129
	Date:	28.04.1982
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 15.10.1981 takes the place of the publication of the European patent application.
	[1982/17]
	Type:	B1 Patent specification
	No.:	EP0050129
	Date:	18.03.1992
	Language:	EN
	[1992/12]
Search report(s)
Classification	IPC:	C12P21/08, C07G17/00, C12N5/12, G01N33/00, A61K37/00, A61K39/00	[1992/12]
	CPC:	C07K16/249 (EP)
	Former IPC [1982/17]	C12P1/00, C07G7/00, C12N15/00, G01N33/54, C12R1/91, C12N5/00, A61K45/02
Designated contracting states	AT, CH, DE, FR, LI, LU, NL, SE [1982/17]
Title	German:	MONOKLONALE ANTIKÖRPER	[1982/17]
	English:	MONOCLONAL ANTIBODY	[1982/17]
	French:	ANTICORPS MONOCLONAL	[1982/17]
Entry into regional phase	09.12.1981	National basic fee paid
	09.12.1981	Designation fee(s) paid
	09.12.1981	Examination fee paid
Examination procedure	09.12.1981	Examination requested [1982/17]
	01.09.1982	Despatch of a communication from the examining division (Time limit: M04)
	27.12.1982	Reply to a communication from the examining division
	09.05.1983	Despatch of a communication from the examining division (Time limit: M06)
	14.11.1983	Reply to a communication from the examining division
	28.03.1984	Despatch of a communication from the examining division (Time limit: M04)
	30.07.1984	Reply to a communication from the examining division
	27.12.1984	Despatch of a communication from the examining division (Time limit: M10)
	28.10.1985	Reply to a communication from the examining division
	21.02.1990	Despatch of a communication from the examining division (Time limit: M04)
	23.05.1990	Reply to a communication from the examining division
	17.04.1991	Despatch of communication of intention to grant (Approval: No)
	03.09.1991	Despatch of communication of intention to grant (Approval: later approval)
	10.09.1991	Communication of intention to grant the patent
	23.10.1991	Fee for grant paid
	23.10.1991	Fee for publishing/printing paid
Appeal following examination	24.05.1986	Appeal received No. T0299/86
	26.07.1986	Statement of grounds filed
	15.06.1987	Invitation to file observations in an appeal (Time limit: M02) [1987/25]
	14.07.1987	Date of receipt of observations in an appeal [1987/29]
	17.08.1989	Result of appeal procedure: continuation of examination procedure
Opposition(s)	Opponent(s)	01 17.12.1992 26.01.1993 ADMISSIBLE F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Grenzacherstrasse 124 CH-4002 Basel / CH Opponents representative Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstrasse 3 81675 München / DE
		[N/P]
	Former [1993/19]
	Opponent(s)	01 17.12.1992 26.01.1993 ADMISSIBLE F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Grenzacherstrasse 124 CH-4002 Basel / CH Opponents representative VOSSIUS & PARTNER Postfach 86 07 67 D-81634 München / DE
	Former [1993/18]
	Opponent(s)	01 17.12.1992 26.01.1993 ADMISSIBLE F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Grenzacherstrasse 124 CH-4002 Basel / CH Opponents representative VOSSIUS & PARTNER Postfach 86 07 67 D-81634 München / DE
	Former [1993/11]
	Opponent(s)	01 17.12.1992 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Grenzacherstrasse 124 CH-4002 Basel / CH Opponents representative VOSSIUS & PARTNER Postfach 86 07 67 D-81634 München / DE
		02 17.12.1992 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Grenzacherstrasse 124 CH-4002 Basel / CH
	Former [1993/08]
	Opponent(s)	01 17.12.1992 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Grenzacherstrasse 124 CH-4002 Basel / CH Opponents representative VOSSIUS & PARTNER Postfach 86 07 67 D-81634 München / DE
	29.01.1993	Invitation to proprietor to file observations on the notice of opposition
	08.10.1993	Reply of patent proprietor to notice(s) of opposition
	25.01.1994	Despatch of communication that the opposition procedure will be closed
	04.02.1994	Legal effect of closure of opposition procedure [1995/38]
Fees paid	Renewal fee
	15.04.1983	Renewal fee patent year 03
	11.04.1984	Renewal fee patent year 04
	11.04.1985	Renewal fee patent year 05
	25.04.1986	Renewal fee patent year 06
	15.04.1987	Renewal fee patent year 07
	15.04.1988	Renewal fee patent year 08
	11.04.1989	Renewal fee patent year 09
	17.04.1990	Renewal fee patent year 10
	29.04.1991	Renewal fee patent year 11
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[XP]WO8002229
		[ ] - Research Disclosure, No. 183, issued Juny 1979, Industrial Opportunities Ltd. (Homewell, Havant, Hampshire, GB), "The Production of Interferon by Genetic Engineering", see disclosure 16, 18309, page 361-362, especially page 362lines 15-21
		[ ] - Nature, Volume 256, issued August 7, 1975 MacMillan Journals Ltd. (Basingstoke, GB) G. KOHLER et al.: "Continuous Cultures of Fused Cells Secreting Antibody of Oredefined Specificity"see pages 495-497 (cited in the application)
		[XP] - Nature, Volume 285, issued June 12, 1980, MacMillan Journals Ltd. (Basingstoke, GB) DAVID S. SECHER et al.: "A Monoclonal Antibody for Large-Scale Purification of Human Leucocyte Interferon"see pages 446-450
		[XP] - C.R. Acad. Sc. Paris, Serie D, Volume 291, No. 11, issued November 24, 1980, Gauthier Villars (Paris, FR)L. MONTAGNIER et al.: "Isolement d'un Hybrude Cellulaire Produisant un Anticorps Specifique de l'Interferon Leucocytaire Humain" see pages 893-896
		[XP] - Scientific American, Volume 243, No. 4, issued October 1980, (New York, US), CESAR MULSTEIN: "Monoclonal Antibodies" see pages 56-64especially page 63
		[XP] - CHEMICAL ABSTRACTS, Volume 94, No. 19, issued May 11, 1981, (Columbus, Ohio, US), THEAPHIL STAEHELIN et al.: "Production of Hybridomas Secreting Monoclonal Antibodies to the Human Leucocyte Interferons", see page 492, column 2, the Abstract No. 154849m, Proc. Natl. Acad. Sci. U.S.A. 1981, 78(3)1848-52

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.32; 35p